Our Team
Manju Sharma, Ph.D.
Associate Professor
Division of Physics
Department of Radiation Oncology
Mother, cynophilist, leisure cooking
Meet Dr. Sharma
Manju Sharma, PhD is an Associate Professor and the Physics Site Lead at the Mission Bay Campus of the Department of Radiation Oncology at UCSF. She is a ABR Certified Medical Physicist. Dr. Sharma and has previously worked in the Radiation Oncology department at the University of Rochester Medical Center (URMC) where she was an Assistant Professor. At URMC Dr. Sharma’s work focused on standardization and improvement of brain stereotactic radiation therapy. She has developed software tools for biological modeling of brain metastatic patients.
Dr. Sharma received a Ph.D. in Physics from Panjab University, in India. She got interested in the field of Medical Physics during her stint as a postdoctoral researcher in Radiation Oncology, at the University of Minnesota and Virginia Commonwealth University. She followed her postdoctoral by finishing a CAMPEP Residency from Virginia Commonwealth University
Dr. Sharma’s research interests are in the adaptive radiation therapy and outcome analysis. She is interested in using treatment day patient information to develop adaptive planning strategies and robust optimization methods. She is also interested in pairing biological information in plan adaptation.
Dr. Sharma’s clinical interests are in process mapping and standardization of radiation therapy clinical workflow. She is interested in developing techniques to automate the physics quality assurance processes and easy access to database.
Education
|
Professional Experience
|
Awards & Honors
|
https://scholar.google.com/citations?hl=en&user=Nzo37toAAAAJ&view_op=list_works&sortby=pubdate
Recent Significant PublicationsM Milano, M Sharma, SG Soltys, A Sahgal, KY Usuki, J Grimm, IE Naqa. “Radiation-induced edema after single or multi-fraction stereotactic radiosurgery: A critical review.” Int J of Rad Onc Bio Phys accepted March 101 (2018) 344-357. M Cummings, P Youn, DP Bergsma, KY Usuki, M Sharma, MC Schell, M Milano. “Single fraction radiosurgery using conservative doses for brain metastases: durable responses in select primaries with limited toxicity. Neurosurgery nyx 427 (2017) 1-8. C Guy, K Kharki, M Sharma, S Kim, “Clinical investigation of surface dose in flattening-filter-free beams”. J of Clinical Medical Physics 17 (2016) 140-148. M Sharma, E Fields, D Todor. “A novel two-step optimization scheme for tandem and ovoid (T&O) HDR brachytherapy treatment for locally advanced cervical cancer.” Brachytherapy 14 (2015) 613-618. H Xu, DJ Vile, M Sharma, JJ Gordon, JV Siebers. “Coverage-based planning to accommodate deformable organ variations in prostate cancer treatment”. Med Phys 41 (2014) 101705. SK Hui, G Fairchild, L Kidder, M Sharma, M Bhattacharya, S Jackson, C Le, A Petryk, MS Islam, D Yee. “The influence of therapeutic radiation on the patterns of bone remodeling in ovary-intact and ovariectomized mice”. Calcif Tissue Intl, 92 (2013) 372-384. M Sharma, E Weiss, JV Siebers. “Dose deformation-invariance in adaptive prostate radiation therapy: implication for treatment simulations”. Radiother Oncol 105 (2012) 207-213. SK Hui, M Sharma and M Bhattacharya. “Liquid scintillator based quantitative measurement of dual radioisotopes (3H and 45Ca) in biological samples for bone remodeling studies”. Applied Radiation Isotopes 70 (1) (2012) 63-68. SK Hui, G Fairchild, L Kidder, M Sharma, M Bhattacharya, S Johnson, C Le, D Yee. “Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid”. Calcif Tissue Intl 90 (2012) 40-49. M Sharma, T Santos, N Papanikolopoulos and SK Hui. “On the development of intra-fraction whole body motion tracking during total body irradiation”. J of Biomedical Optics 16 (2011) 1-8. M Sharma, Z Bajzer and SK Hui. “Development of empirical model using 41Ca for the clinical study of bone remodeling”. J of Clinical Pharmacokinetics 3 (2011) 191-199. TO Ely, M Sharma, WK Lesniak, B Foster, B Lajos. “Dendrimer nanocomposites as next generation X-ray contrast agents”. Conference, Nanomedicine: Nanotechnology, Biology, and Medicine 3 (2007) 351.
|